Liquidators for ready-made meals producer Jewel of India have lost their bid to dodge public examination over their alleged poor handling of the business’ sale and failure to investigate potential claims against the Commonwealth Bank.
An appeals court has found that Avant Insurance must indemnify a plastic surgeon for his legal bills and the claims of all relevant group members in a class action over alleged botched breast augmentations.
A judge has denied an “invasive” bid to search hospitality giant Merivale’s payroll systems ahead of an upcoming mediation in a $129 million underpayment class action covering 13,500 employees.
A judge has declined to award costs against a group of nurses who recently dropped their Fair Work lawsuit against Monash Health, saying the case was not “doomed to fail” and noting the “extremity” of the Victorian government’s vaccine mandate for workers.
The High Court has declined special leave to members of the Victorian Labor party to challenge a judge’s finding that the pre-selection of ALP candidates in Victorian electorates by federal administrators during their takeover of the state party was lawful.
A solicitor running two franchisee class actions against 7-Eleven “retaliated” against a group member who objected to a $98 million settlement and issued a late $6.5 million legal bill to benefit a litigation funder, a court has heard.
The senior counsel for Deutsche Bank in its sucessful defence against the ACCC’s landmark cartel case is one of three new judicial appointments in NSW.
The structural engineer behind Sydney’s Opal Tower has taken builder Icon’s insurers to court, arguing they should cover its costs in a class action brought on behalf of residents of the ill-fated building and related litigation.
Questions raised about the structure of a settlement of two wage class actions against supermarket chain Romeo’s don’t just threaten to reduce the law firm’s costs but could derail the whole agreement, a judge has said.
The Federal Court has signed off on a settlement between two US biotech companies that ends a dispute over the companies’ ‘Access’ trade marks in Australia.